Question 1

Does Squarepoint Ops own XLO stock?

Accepted Answer

No. Squarepoint Ops exited its XLO (Xilio Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 328,794 shares worth $277,075.

Question 2

How many shares of XLO does Squarepoint Ops own?

Accepted Answer

None since Q4 2025, when Squarepoint Ops exited the position. Its Q3 2025 13F listed 328,794 shares worth $277,075.

Question 3

What is Squarepoint Ops' XLO position worth?

Accepted Answer

Squarepoint Ops' XLO position was worth $277,075 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Squarepoint Ops buying or selling XLO?

Accepted Answer

In Q4 2025, Squarepoint Ops exited its entire XLO position.

Question 5

When did Squarepoint Ops first buy XLO?

Accepted Answer

Squarepoint Ops first reported XLO in its Q2 2025 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$8.96	0
2025-Q3	Increased	328,794	+39.6%	$277,075	0.0%	$11.80	31
2025-Q2	New	235,456	—	$160,087	0.0%	$9.52	31